View external media coverage about Appriss to learn what’s happening.
For media inquiries, please visit our inquiries page.
The opioid epidemic is a growing and complex problem. In fact, the Centers for Disease Control (CDC) estimates that more than 71,000 people in the U.S. died from drug overdose deaths in 2017.
This week, Appriss Health has launched ApprissID, a patient record-matching solution based on machine learning and consolidation algorithms within PMP AWARxE, Appriss Health’s prescription drug monitoring program (PDMP) solution that serves 44…
This session on May 7th at the RILA Asset Protect conference will include Chris Hoffman, Appriss Retail’s senior program manager, as well as two speakers from PetSmart.
Employee theft and fraud are costly problems for the retail industry, and the best techniques for reducing it are continuing to evolve. On this recorded webinar, two of the biggest names in retail risk management—First Advantage and Appriss…
Round table discussion led by Ken George, EMEA Business Development Manager, at Retail Risk London on 11 April 2019.
A private-equity firm will make a significant investment in Appriss Holdings Inc. and will become an equal partner in the company with Appriss management and another investor.
Partners HealthCare is the first health system to fully integrate the Massachusetts opioid monitoring tool directly into its EHR.
Partners HealthCare has integrated the Commonwealth of Massachusetts’ Prescription Awareness Tool (MassPAT) directly into its Epic electronic health record (EHR) system. The Boston-based health system says this makes it the first healthcare…
Written by David Speights, Ph.D. A growing retailer’s best chance to compete against giants such as Amazon is by having a well-developed AI strategy. This article explores what qualifies as AI for profit protection, how it helps with…